Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs)
play a role in the treatment of hypertension (HTN) and heart failure (HF). The literature …

Most guidelines for the management of patients with cardiovascular disease recommend
angiotensin-converting enzyme (ACE) inhibitors as first-choice therapy, whereas …

Angiotensin-converting enzyme inhibitors (ACEIs) are considered primary drugs for the
secondary prevention of myocardial infarction (MI), and angiotensin receptor blockers …

Abstract Purpose of Review Angiotensin-converting enzyme inhibitors and angiotensin
receptor blockers are commonly used anti-hypertensive medications in a number of clinical …

J Clin Hypertens (Greenwich). 2012; 14: 407–414.© 2012 Wiley Periodicals, Inc. Important
questions concerning the comparative effectiveness of angiotensin‐converting enzyme …

ACE (angiotensin-converting enzyme) inhibitors and angiotensin receptor blockers (ARBs)
are equally guideline-recommended first-line treatments for hypertension, yet few head-to …

Arterial hypertension is the main preventable cause of premature mortality worldwide.
Across Latin America, hypertension has an estimated prevalence of 25.5–52.5%, although …

Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers | AAFP
Advertisement search close brand logo BACHIR TAZKARJI, MD, AND AMBIKA …

Renin-angiotensin-aldosterone system (RAAS) inhibitors, including angiotensin-converting
enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs), are commonly used in …

Prevention of coronary artery disease (CAD) events is an essential target in the
management of hypertension. A series of meta-analyses have now provided proof of clear …